Effect of aspirin on biomarkers of barrett's esophagus after successful eradication of barrett's esophagus with radiofrequency ablation

Ended Awarded Last action

Contract number
HHSN26100007
Awardee
Awarding agency
Obligated
$846,289

Award facts

Opportunity
  • S2014 Solicitation number
Contract value 100% obligated
$846,288.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Houston, TX 77030, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 $2,604
Funding Only Action P00005 -$7,746
Other Administrative Action P00004 · Clinical prevention agent development program: early phase clinical research task order title: effect of aspirin on biomarkers of barrett's esophagus after… $0
Other Administrative Action P00003 $0
Change Order 2 -$1,186
Funding Only Action 1 · Base contract title: clinical prevention agent development program: early phase clinical researchtask order title: effect of aspirin on biomarkers of… -$29,740
Original award $882,357

About this award

The National Cancer Institute issued a delivery order to The University of Texas M.D. Anderson Cancer Center on June 15, 2015, with a ceiling value of $846,288.93, for a clinical prevention research study examining the effect of aspirin on biomarkers of Barrett's esophagus after successful eradication with radiofrequency ablation.

This delivery order was issued under the Cancer Prevention Agent Development Program 2012-2017 IDIQ. Place of performance is Houston, TX. The order ultimate completion date was May 31, 2021. Pricing is cost no fee, and no set-aside was used.

Service Contract Inventory data for FY2021 shows $60 thousand invoiced with no subcontractors reported; MD Anderson self-performed all reported labor.

Quick answers

Who was awarded contract HHSN26100007?

HHSN26100007 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on June 15, 2015.

How much is contract HHSN26100007 worth?

The government has obligated $846,289 on HHSN26100007.

Is contract HHSN26100007 an order under another contract?

Yes. HHSN26100007 is a delivery order under HHSN261201200034I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100007 competed?

The extent of competition for HHSN26100007 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award